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Abstract
Ischaemia-reperfusion injury (IRI) is the leading cause 
of injury seen in the liver following transplantation. 
IRI also causes injury following liver surgery and 
haemodynamic shock. The first cells within the liver to 
be injured by IRI are the liver sinusoidal endothelial 
cells (LSEC). Recent evidence suggests that LSEC co-
ordinate and regulates the livers response to a variety 
of injuries. It is becoming increasingly apparent that 
the cyto-protective cellular process of autophagy is a 
key regulator of IRI. In particular LSEC autophagy may 
be an essential gatekeeper to the development of IRI. 
The recent availability of liver perfusion devices has 
allowed for the therapeutic targeting of autophagy to 
reduce IRI. In particular normothermic machine liver 
perfusion (NMP-L) allow the delivery of pharmacological 
agents to donor livers whilst maintaining physiological 
temperature and hepatic flow rates. In this review we 
summarise the current understanding of endothelial 
autophagy and how this may be manipulated during 
NMP-L to reduce liver IRI. 
Key words: Autophagy; Liver transplant; Ischaemia-
reperfusion injury; Normothermic machine liver 
perfusion
© The Author(s) 2017. Published by Baishideng Publishing 
Group Inc. All rights reserved.
 
Core tip: Liver sinusoidal endothelial cells autophagy 
regulates liver ischaemia reperfusion injury and this 
process can be targeted for therapeutic benefit using 
normothermic machine liver perfusion.
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INTRODUCTION
The term autophagy is derived from the Greek 
meaning “eating of self” and the precise cellular role 
of autophagy has been controversial[1]. However 
research over the past decade has demonstrated that 
the evolutionarily conserved process of autophagy is 
primarily a cell survival mechanism allowing cells and 
tissues to maintain homeostasis during periods of 
stress such as starvation and ischaemia[2]. Specifically 
autophagy eliminates damaged organelles, long-
lived proteins or intracellular pathogens through the 
co-ordinated engulfment of the targeted cargo in a 
double membrane cytoplasmic structure known as 
an autophagosome[3,4]. Autophagosomes then fuse 
with lysosomes to form autophagolysosomes that 
degrade the engulfed cargo allowing their reuse 
and thus potentially negating periods of cellular 
stress[2,4-6]. Hence unsurprisingly autophagy is involved 
in number of cellular processes such as metabolism, 
protein synthesis and cellular transportation[4,7]. 
Dysregulated or uncoordinated autophagy is linked to 
cell injury and a number of disease processes such as 
neurodegenerative diseases and cancer[2,4,6,7]. 
Three distinct types of autophagy have been 
characterised. The mostly widely studied is macro-
autophagy (referred to as autophagy hereafter) and is 
the primary focus of this review[4,5,8]. Micro-autophagy 
is characterized by the invagination of the target by the 
lysosomal membrane itself[5,9]. Chaperone-mediated 
autophagy targets proteins with the KFERQ motif to 
the lysosome via interaction with lysosomal-associated 
membrane protein (LAMP)[9,10]. More recently dis-
tinct macroautophagy signalling pathways have 
been characterised that are activated to specifically 
eliminate portions of the cell and/or cytoplasm leading 
to the characterisation of mitophagy (mitochondria), 
ERphagy (endoplasmic reticulum), xenophagy 
(microorganisms), lipophagy (lipids) and ribophagy 
(ribosomes). It is becoming increasingly apparent 
that specific forms of autophagy are important in the 
development and pathophysiology of different disease 
processes. The precise regulation of each type of 
autophagy is beyond the scope of this review but the 
reader is referred to recent excellent reviews on the 
subject[2,4,6,7]. 
The therapeutic targeting of autophagy has ga-
thered momentum since the publication of the first 
clinical trials using autophagy inhibitors in treatment of 
cancers[11-13]. For instance autophagy inhibitors (e.g., 
hydroxychloroquine) were used in combination with 
chemotherapy in patients with advanced pancreatic 
cancer and in those patients with increased levels 
of the autophagy marker LC3 in peripheral blood 
mononuclear cells there was an improvement in 
disease free and patient survival[11]. However in 
other trials using hydroxychloroquine in patients 
with glioblastoma the optimal therapeutic dose was 
not found due to the marked side effects with the 
investigators concluding that drugs with less toxicity 
should be awaited[12]. Although these studies have 
provided the impetus to manipulate autophagy it still 
remains to be established whether autophagy should 
be activated or inhibited to derive therapeutic benefit 
in many disease processes. Moreover many groups 
working on the therapeutic manipulation of autophagy 
are now suggesting that the targeting of autophagy 
during pathophysiological processes needs to tissue 
and possibly even cell specific[14].
The use of autophagy as a target in treating 
liver diseases have been the focus of intense recent 
research[15]. Indeed the manipulation of autophagy may 
be useful in treating many liver diseases. For instance 
induction of autophagy/lipophagy may reduce steatosis 
in fatty liver disease[16] and inhibiting autophagy 
in hepatobiliary cancers may promote cancer cell 
death[11,17]. The manipulation of the autophagy signalling 
pathway also holds significant promise in attempting to 
reduce the liver ischaemia-reperfusion injury (IRI). IRI 
is an antigen independent pro-inflammatory process 
that mediates liver injury following transplantation, 
liver surgery and haemorrhagic shock[18]. The injury 
occurs in two distinct phases. In the ischaemia phase 
blood flow to the liver is interrupted leading to tissue 
hypoxia and the generation of reactive oxygen species 
(ROS). During the reperfusion phase although blood 
flow to the liver is restored there is a concomitant 
increase in pro-inflammatory mediators, ROS and 
inflammatory cells that amplifies the liver injury[18]. 
It is well established that IRI targets and injuries the 
liver parenchymal cells such as hepatocytes and liver 
sinusoidal endothelial cells (LSEC)[19]. However early 
IRI is characterised by LSEC injury and dysfunction[19]. 
Indeed recent studies demonstrate the key role of 
LSEC in co-ordinating the livers response to injury 
whilst also mediating the recovery from liver injury[20]. 
Thus the targeting of autophagy in the LSEC during IRI 
is an attractive method with which to reduce liver IRI. 
The emerging technology of normothermic ma-
chine perfusion of the liver (NMP-L) provides an 
exciting modality with which to target autophagy in 
LSEC whilst simultaneously allowing an assessment 
of liver function[21]. There are different NMP-L devices 
available allowing either selective hepatic artery 
perfusion or dual hepatic perfusion of donor livers. 
Using primarily blood based perfusion fluids, oxygen is 
delivered to donor livers whilst maintaining a normal 
8444 December 28, 2017|Volume 23|Issue 48|WJG|www.wjgnet.com
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temperature (37 ℃). NMP-L is typically performed for 
6 h and the sequential sampling of perfusates and liver 
tissue allows a dynamic assessment of liver function. 
One of the many potential benefits of NMP-L is the 
reduction in the liver IRI. Therefore, the manipulation 
of autophagy in LSEC during NMP-L is an attractive 
therapeutic target with which to improve donor liver 
organ function prior to transplantation.
 
AUTOPHAGY SIGNALLING PATHWAY 
The autophagy signalling pathway is regulated by 
specific and dedicated cellular machinery. These 
proteins were first isolated in yeast two-hybrid screens 
and are now known as the Autophagy-related proteins 
(ATGs). To date 30 ATGs have been characterised 
that are essential for autophagy induction. Recent 
reviews by Stork et al[21] provide an in-depth review 
of the pathway whilst a brief overview is given here. 
In general the autophagy signalling pathway can be 
divided into distinct phases including the initiation, 
elongation, autophagosome formation, fusion and 
autophagolysosomal formation (Figure 1). 
The formation of autophagosomes commences 
upon omegasomes and is known as the initiation 
phase[22]. This process is regulated by the ATG proteins 
unc-51 like autophagy activation kinase (ULK1) and 
WIPI1-4/ATG18[22,23]. Starvation is a classical activator 
of autophagy and in nutrient rich conditions the 
activation of autophagy is inhibited by Mammalian 
Target of Rapamycin (mTOR)[24]. However when 
autophagy is activated, the inhibitory effect of mTOR is 
lost allowing for the activation of ULK1 kinase complex 
during the initiation phase[9]. In addition autophagy 
can also be initiated by AMP-activated protein 
kinase (AMPK)[25] (Figure 1). Subsequently there is 
8445 December 28, 2017|Volume 23|Issue 48|WJG|www.wjgnet.com
Figure 1  Autophagy signalling pathways. Upstream autophagy activation is regulated by the integration of signalling from a number of pathways including AMPK, 
PI-3K and the Mitogen-Activated Protein Kinases. Phagophore initiation is directly regulated by the serine/threonine protein kinases ULK1 that forms a complex with 
Beclin 1. Upon initiation, cytoplasmic constituents are enclosed in a double membraned isolation structure known as an autophagosome that is elongated mainly 
through the action of two ubiquitin-like conjugation systems. Autophagosomes fuse with lysosomes to form autophagolysosomes, where breakdown of the vesicle 
contents/cargo takes place along with the autophagosome inner membrane. Autophagy can be activated by many stimuli including starvation, toxins, oxidative stress 
and infections. (Taken from Shan NN et al Targeting autophagy as a potential therapeutic approach for immune thrombocytopenia therapy. Crit Rev Oncol Hematol 
2016; 100: 11-15. DOI: 10.1016/j.critrevonc.2016.01.011).
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AUTOPHAGY AND ENDOTHELIAL CELLS
Regulation of autophagy activation in endothelial cells 
Much of our understanding of the role of autophagy 
in endothelial cells, such as LSEC, has come from 
the study of endothelial cell biology in cardiovascular 
disease. Recent studies have demonstrated how 
autophagy dysfunction in endothelial cells contributes 
to the pathogenesis of arthrosclerosis by regulating 
angiogenesis, haemostasis and nitric oxide pro-
duction[9]. 
In endothelial cells upstream activation of the 
autophagy is regulated by the integration of signalling 
from the AMPK and mTOR-ULK1 pathways[9] (Figure 1). 
AMPK can detect decreases in cellular ATP levels and 
activate autophagy primarily to provide substrates for 
energy used for essential cellular processes[9,29] (Figure 
2). Specifically AMPK phosphorylates the Tuberous 
Sclerosis 2 (TSC2) protein that inhibits mTOR and 
activates autophagy in an analogous mechanism 
to that seen during starvation[9,29-33]. In HeLa cells 
starvation increases intracellular calcium levels and can 
activate AMPK through Calmodulin-dependent protein 
kinase kinase-β (CaMKK-β) that then subsequently 
activates autophagy[9,34,35]. In endothelial cells CaMKK-β 
mediated AMPK activation inhibits mTOR leading to 
ULK1 upregulation and autophagy activation[34]. Thus 
in endothelial cells the activation of autophagy is a 
dynamic interplay between AMPK, intracellular calcium, 
mTOR and ULK-1.
recruitment of class Ⅲ phosphatidylinositol 3-kinase 
(PI3-K), Vps34 and Beclin-1/ATG6 to the developing 
autophagosome[5,9]. ULK1 is then able to activate the 
PI3-K complex leading to the activation of Beclin-1 and 
the later phases of autophagy. This pathway details 
the canonical autophagy signalling pathway but recent 
evidence suggests that autophagy can be activated 
by Beclin-1 independent mechanisms/non-canonical 
pathways too[9,26]. 
The elongation phase of autophagy involves two 
separate ATG conjugation systems. Firstly ATG12 
conjugates ATG5 via ATG7/ATG10. The ATG12-ATG5 
complex is then able to interact with ATG16 resulting in 
the formation of the ATG12-ATG5-ATG16L complex[5,27]. 
The second conjugation system involves LC3-I/ATG8 
that is cleaved by ATG4 in a process requiring ATG7 
and ATG3. This culminates in the formation of LC3-
Ⅱ[5,28]. Both these conjugation systems are integral 
to autophagosome membrane expansion[4,7,9]. At 
the point at which appropriate membrane expansion 
has been reached there is closure of double layered 
membrane that is regulated by amongst other proteins 
the docking protein p62 which is located on the outer 
membrane of the autophagosome and is responsible 
for docking with the lysosome via a dynein-dependent 
mechanism[5]. Thereafter, lysosomal acid hydrolases 
degrade the engulfed content/cargo and lysosomal 
efflux permeases release the final products to the 
cytosol for anabolic processes (Figure 1). 
Autophagy activation/induction
Boteon YL et  al.  Endothelial cell autophagy
Figure 2  Autophagy activation in endothelial cells. A number of mechanisms potentially regulate autophagy activation in endothelial cells. A decrease in cellular 
ATP or reduction in growth factors availability leads to the activation of AMP-activated protein kinase (AMPK). Once activated AMPK can inhibit mTOR leading to the 
activation of ULK1 and hence autophagy activation. In addition decreases in intracellular calcium can activate CaMKK-β leading to mTOR inhibition and autophagy 
activation. Moreover, Sirt1 can activate autophagy via deacetylation of ATG5, ATG7, ATG8 and increased transcription of FoxO1 and FoxO3 that then regulate the 
expression ATGs via deacetylation of Akt. Reactive oxygen species (ROS) and shear stress are important regulators of Sirt1 activity.
ROS
Shear stress
Sirt 1
ATG5
ATG7
ATG8
FoxO1
FoxO3
ATP levels Intracellular
calcium
AMPK CaMKK-β
mTOR
ULK1
8447 December 28, 2017|Volume 23|Issue 48|WJG|www.wjgnet.com
The deacylation protein Sirt1 has attracted recent 
attention as an important regulator of autophagy 
activation. Specifically Sirt1 can deacetylate ATG5, 
ATG7, and ATG8[9,36] whilst activating the transcription 
factors Forkhead box O (FoxO) FoxO1 and FoxO3. Both 
FoxO1 and FoxO3 can regulate the expression of ATGs 
via deacetylation of Akt[9,35,37-39]. Indeed during liver 
IRI ROS can regulate the activation of Sirt1, which 
may have important implications for endothelial cell 
autophagy during NMP-L[9,40-43]. Specifically perfusion 
fluid used during NMP-L induces tangential force 
across the endothelium causing shear stress that is 
associated with autophagy activation via the Sirt1-
FoxO pathway[43]. Low shear stress is associated with 
reduced levels of autophagy suggesting an important 
relationship between shear stress and autophagy[44]. 
Therefore autophagy activation in endothelial cell can 
be regulated by multiple signalling pathways and at 
present is remains to be established which of these 
pathways is important during NMP-L. 
Effects of autophagy on endothelial cell function
Autophagy activation has recently been demonstrated 
to have a number of important effects upon endothelial 
cell function. Following endothelial injury exposure 
of the sub-intimal layer promotes glycoproteins, 
expressed on platelets, to bind to subendothelial von 
Willebrand Factors (vWF) leading to the formation of 
a platelet thrombus and production of thromboxane 
A2, serotonin and adenosine diphosphate[34].  Recent 
studies demonstrate that vWF is found in close pro-
ximity to autophagosomes in endothelial cells[35]. The 
inhibition of autophagy impairs the secretion of vWF 
from endothelial cells suggesting that endothelial cell 
autophagy may have an anti-thrombotic function[45].
In endothelial cells, endothelial nitric oxide synthase 
(eNOS) regulates nitric oxide (NO) production that in 
turn regulates vascular tone, platelet aggregation and 
leukocyte adhesion[46]. Indeed this may be a central 
function of endothelial cells during liver IRI and a 
potential protective mechanism induced within the liver 
by NMP-L. Furthermore eNOS can regulate autophagy 
induction[47,48]. The exact mechanisms involved in 
eNOS/NO-autophagy axis are not yet understood 
although impaired autophagy does result in reduced 
eNOS function reduced NO production[49]. 
As eluded to earlier blood flow within the liver 
generates shear stress across the endothelium that 
is associated with induction of eNOS and NO pro-
duction[50]. This is in turn associated with a reduction 
in oxidative stress and inflammation in endothelial 
cells. Disturbed shear stress generated by non-
laminar flow is associated with endothelial dysfunction 
that can be implicated in disease processes such as 
arthrosclerosis[50]. Hence low shear induces autophagy 
dysfunction[48] which is associated with insufficient 
autophagy activation in endothelial cells and thus 
endothelial dysfunction[43]. NMP-L may aid endothelial 
cell autophagy by ensuring laminar flow within the 
hepatic vasculature thereby prompting autophagy 
leading to increased eNOS transcription and NO 
production. In summary, physiologic shear stress is an 
essential mechanism for the maintenance of endothelial 
cells function and is in part mediated by autophagy 
activation[47].
Autophagy activation is also associated with an-
giogenesis in endothelial cells particularly within 
ischaemic microenvironments[51]. The relationship 
between redox signalling and autophagy is complex 
and out of the scope of this review although it has 
been recently reviewed[42]. Autophagy regulation 
of angiogenesis appears to be dependent upon the 
activation of the Akt signalling pathway in endothelial 
cells although the precise mechanism remains to be 
determined[9,51,52]. 
Therapeutic targeting of autophagy in endothelial cells
The evolving understanding of the autophagy signalling 
pathway has lead to the targeting of the pathway for 
potential therapeutic benefit in many clinical scenarios. 
However what is becoming evident from these studies 
is that for the successful therapeutic targeting of 
autophagy the timing of the intervention, the part 
of the autophagy pathway targeted, the cell type 
targeted and whether autophagy should be inhibited 
or activated are all critical factors. The targeting of 
autophagy within endothelial cells remains a nascent 
field with few studies investigating this area.
Epigallocatechin gallate, found in green tea, can 
induce the specific form of autophagy known as 
lipophagy in endothelial cells. Lipophagy causes the 
specific elimination of lipid droplets. In artheroscelosis 
the degradation of lipid droplets in vascular endothelial 
cells can potentially modulate the disease process 
by allowing endothelial cells to resist the effects of 
lipotoxicity[35,53]. In human umbilical vein endothelial 
cells (HUVEC) exposed to oxidative stress, vitamin D 
dependent autophagy activation prevents cell death 
by activating Beclin1 that prevents mitochondrial 
depolarisation and caspase activation[54]. Pterostilbene 
can activate AMPK to stimulate autophagy in HUVEC 
promoting the elimination of excess lipids and thus 
reducing apoptosis[53] whilst other groups have suggest 
that Advanced glycation end-products (AGEs) may 
regulate the activation of autophagy in this scenario[55]. 
Furthermore the autophagy activator rapamycin can 
increase the viability of HUVEC during starvation[56]. 
These limited studies do suggest that selective 
activation of autophagy in cells of endothelial lineage 
promotes cell survival. 
Very few studies have addressed the role of 
autophagy in endothelial cells in vivo. Torisu et al[45] 
reported, using a Cre-lox conditional ATG7 endothelial 
knockdown mice, that inhibition of autophagy leads 
a reduction in the secretion of vWF suggesting that 
autophagy may have a role in preventing thrombosis. 
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However the role of endothelial cell autophagy in vivo 
need much more investigation.
THERAPEUTIC MANIPULATION OF 
ENDOTHELIAL CELL AUTOPHAGY 
DURING NMP-L
NMP-L is a novel technique that can be employed 
to assess and recondition donor livers prior to tran-
splantation. One of the potential benefits of NMP-L is 
the potential reduction in liver IRI especially when 
compared to traditional static cold storage[57,58]. 
Recent studies have established haemodynamic and 
biochemical parameters that allow donor livers to 
be classified as viable and non-viable where viable 
denotes a liver that can be transplanted following 
NMP-L. Indeed donor livers represent conditions 
were autophagy is expected to be activated; relative 
tissue ischaemia and reduced availability of nutrients. 
Recent data from our laboratory has shown that donor 
livers that demonstrate these viability criteria shows 
increased levels of autophagy within hepatic sinusoids 
as assessed by immunohistochemical analysis of 
the specific autophagy marker LC3B (Figure 3). This 
suggests a relationship between autophagy induction 
and liver viability although further work is needed to 
fully establish this relationship. 
As discussed above targeting of autophagy needs 
to be considered in terms of the timing of intervention, 
the cell type targeted and the part of the autophagy 
pathway targeted. During NMP-L there are two forms 
of intervention that could modulate autophagy in 
endothelial cells; mechanical or pharmacological. 
Livers exposed to NMP-L are associated with 
increased cellular ATP levels in comparison to cold 
static stored livers. For instance in a porcine model of 
donation after cardiac death (DCD) livers exposed to 
1 h warm ischaemia, followed by 2 h of cold ischaemia 
and then 4 h of NMP-L increased cellular ATP levels 
by 80% in comparison with livers maintained in cold 
static storage for 2 h[59]. Higher ATP levels within liver 
grafts prior to liver transplantation are associated with 
better patient outcomes in some series[60,61]. Although 
it must be remembered that these studies have 
assessed global liver ATP levels and not specifically 
LSEC ATP levels. Additionally, NMP-L is associated 
with preservation of liver architecture and integrity of 
the mitochondria[59]. The regulation of mitochondrial 
function and number is regulated in large part by the 
specific autophagy process termed mitophagy[62]. The 
regulation of mitophagy during NMP-L and liver IRI is 
now being actively investigated as a potential method 
to reduce liver injury following transplantation[62]. The 
manipulation of mitophagy in LSEC is emerging as a 
method to reduce liver injury. However despite this it 
remains to be established whether LSEC autophagy 
contributes to increased ATP levels during NMP-L 
and whether autophagy, through promoting survival 
of LSEC, improves the survival of neighbouring liver 
parenchymal cells. 
NMP-L may also regulate autophagy activation 
through calcium signalling. During NMP-L the perfusion 
fluid is supplemented with calcium to maintain 
physiological extracellular levels of the ion ensuring 
that the electrochemical gradient of calcium is 
maintained across cell membranes[58]. Low intracellular 
levels of calcium are reported to induce CaMMk-β 
activation followed by mTOR inhibition and therefore 
ULK1/autophagy activation[34]. Physiological calcium 
levels during NMP-L potentially promote normal 
autophagy activity within LSEC and other liver cells 
ensuring homeostasis is maintained.       
The mechanical manipulation of autophagy during 
Viable                                              Non-viable
Prior to NMP-L
After 6 h of NMP-L
Figure 3  Autophagy and liver viability following normothermic machine liver perfusion. Immunohistochemical analysis was performed for the autophagy 
protein LC3B in liver tissue prior to normothermic machine liver perfusion (NMP-L) and after 6 h of NMP-L. Livers deemed viable after NMP-L demonstrated LC3B 
immunostaining in the hepatic sinusoids prior to commencing NMP-L and at the end of perfusion. Donor livers not fulfilling viability criteria demonstrated no LC3B 
Immunostaining.
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NMP-L is dependent upon shear stress. NMP-L has the 
advantage of providing an adjustable vascular/laminar 
flow rate to livers. In turn these flow rate provides 
a near physiological shear stress known to promote 
autophagy induction[43]. Activated autophagy in 
endothelial cells is fundamental for eNOS transcription, 
NO production and maintenance of vascular tone 
maintenance[47]. Increased NO may also reduce platelet 
aggregation and leukocyte adhesion in endothelial 
cells thus reducing IRI and hepatic microcirculatory 
disturbance[63].  
Pharmacological modulation of autophagy during 
NMP-L may also allow the targeting of endothelial cells 
dysfunction in donor liver grafts prior to transplantation. 
Extended criteria liver donors (e.g., DCD grafts and 
steatotic grafts) tend to be associated with lower cellular 
ATP content and increased ROS production increasing 
their susceptibility to IRI[57,59]. Pharmacological agents 
promoting activation of autophagy during NMP-L 
may promote elimination of damaged organelles and 
toxins prior to graft implantation. In particular aiding 
mitophagy function may be crucial to maintaining LSEC 
function during NMP-L and thus aiding the survival 
of other liver cells. As described above, many drugs 
are already known to regulate autophagy activation 
and the use of these drugs in experimental NMP-L 
perfusion offers an important method to evaluate 
these interventions. This manipulation of autophagy 
in LSEC using NMP-L is an exciting area of interest for 
research groups working on liver IRI particularly as this 
technology will become more widespread in addition to 
the development of new autophagy modulating drugs. 
CONCLUSION 
In summary, autophagy is a complex metabolic 
process that is essential for the cell survival; it 
promotes clearance of harmful substances and 
provides energy to the cell during cellular stress. 
The role of autophagy in endothelial cells and its 
manipulation using NMP-L offers significant promise 
in reducing liver IRI thereby improving the quality of 
donor liver organs used for transplantation.
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